CLINICAL_TRIALS
research
· 2024-12-12
Clinical Trial Update: Nicotinamide Supplementation in Glaucoma [Phase 3]
Summary
A Phase 3 clinical trial is evaluating nicotinamide supplementation for glaucoma and is currently enrolling by invitation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Singapore Eye Research Institute | Conditions: Glaucoma | Phase 3 | Status: ENROLLING_BY_INVITATION